The Global Tuberculosis Report 2019 provides important evidence on the challenge in tackling tuberculosis as an issue of global public health importance. We remain committed to the global effort and the World Health Organisation End Tuberculosis Strategy. We are proud to be at the forefront of work to prevent, detect and treat tuberculosis, including funding research to develop new treatments to tackle drug resistant tuberculosis. Our commitment to provide £1.4 billion to the latest replenishment of the Global Fund will help provide tuberculosis treatment and care for over 2 million people.<\/p>
<\/p>
A new tuberculosis vaccine could potentially have a significant effect on reducing tuberculosis deaths, and there is cautious optimism about the results for one potential vaccine, although there is still a very high degree of uncertainty for this high-risk research. DFID carefully considers robust data on specific vaccines before taking a view on its role in tackling a disease, including its relative impact alongside other established interventions.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/1466", "label" : {"_value" : "Biography information for Dr Andrew Murrison"} } , "answeringMemberConstituency" : {"_value" : "South West Wiltshire"} , "answeringMemberPrinted" : {"_value" : "Dr Andrew Murrison"} , "dateOfAnswer" : {"_value" : "2019-10-30", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2019-10-30T13:21:08.083Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "20"} , "answeringDeptShortName" : {"_value" : "International Development"} , "answeringDeptSortName" : {"_value" : "International Development"} , "date" : {"_value" : "2019-10-24", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Developing Countries: Tuberculosis"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for International Development, what assessment his department has made of (a) the implications for his policies of the WHO report entitled Global Tuberculosis Report 2019 and (b) the potential effect of a new TB vaccine on achieving the (i) SDG target of ending the TB epidemic by 2030 and (ii) WHO End TB Strategy of reducing TB deaths by 95% and cutting new cases of TB by 90% between 2015 and 2035.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4056", "label" : {"_value" : "Biography information for Nic Dakin"} } , "tablingMemberConstituency" : {"_value" : "Scunthorpe"} , "tablingMemberPrinted" : [{"_value" : "Nic Dakin"} ], "uin" : "4996"} , {"_about" : "http://data.parliament.uk/resources/1130466", "AnsweringBody" : [{"_value" : "Department for International Development"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1130466/answer", "answerText" : {"_value" : "
The UK Government recognises that strengthening TB prevention, diagnosis and treatment contributes to preventing antimicrobial resistance (AMR) and strengthening health systems.<\/p>
<\/p>
Drug-resistant TB currently accounts for one-third of all deaths from AMR. The UK is leading work on development of new antibiotics and treatment combinations and new ways to rapidly test for drug resistance. DFID\u2019s support to the Global Fund helps to ensure rapid rollout of new tools. For example, UK funding has helped to roll out a new multi-drug-resistant TB treatment regimen in 30 countries where the Global Fund operates.<\/p>
<\/p>
Strengthening TB prevention, diagnosis and treatment also contributes to strengthening broader health systems. The UK\u2019s investment in the Global Fund is building national capability to deliver quality health services and contributing to Universal Health Coverage and to ensuring that no country and no person is left behind.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/1466", "label" : {"_value" : "Biography information for Dr Andrew Murrison"} } , "answeringMemberConstituency" : {"_value" : "South West Wiltshire"} , "answeringMemberPrinted" : {"_value" : "Dr Andrew Murrison"} , "dateOfAnswer" : {"_value" : "2019-06-13", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2019-06-13T15:33:41.517Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "20"} , "answeringDeptShortName" : {"_value" : "International Development"} , "answeringDeptSortName" : {"_value" : "International Development"} , "date" : {"_value" : "2019-06-06", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Developing Countries: Tuberculosis"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for International Development, what assessment he has made of the potential effect of strengthening TB prevention, diagnosis and treatment on (a) rates of antimicrobial resistance and (b) health systems around the world.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4056", "label" : {"_value" : "Biography information for Nic Dakin"} } , "tablingMemberConstituency" : {"_value" : "Scunthorpe"} , "tablingMemberPrinted" : [{"_value" : "Nic Dakin"} ], "uin" : "261205"} ], "itemsPerPage" : 10, "page" : 0, "startIndex" : 1, "totalResults" : 2, "type" : ["http://purl.org/linked-data/api/vocab#ListEndpoint", "http://purl.org/linked-data/api/vocab#Page"]} }